These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12966934)

  • 61. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 62. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 63. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 64. [Heparin-induced thrombocytopenia (HIT). Problems and their significance for ENT medicine].
    Kleinschmidt S; Mertzlufft F; Bach F; Plinkert PK
    HNO; 2001 Oct; 49(10):854-64; quiz 865, 867. PubMed ID: 11699150
    [No Abstract]   [Full Text] [Related]  

  • 65. Venous thromboembolism in heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2000 Jul; 6(4):343-51. PubMed ID: 10912644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
    Horlait G; Minet V; Mullier F; Michaux I
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):193-197. PubMed ID: 27100305
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
    Wilhelm MJ; Schmid C; Kececioglu D; Möllhoff T; Ostermann H; Scheld HH
    Ann Thorac Surg; 1996 Mar; 61(3):920-4. PubMed ID: 8619718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
    Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
    Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 70. Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatment.
    Boon DM; Kappers-Klunne MC; Michiels JJ; Stibbe J; van Vliet HH
    Neth J Med; 1995 Mar; 46(3):146-52. PubMed ID: 7731489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heparin-induced thrombocytopenia in France, 1980-1998.
    Nguyen P; de Maistre E; Cornillet-Lefebvre P; Regnault V; Lecompte T
    Semin Thromb Hemost; 1999; 25 Suppl 1():9-15. PubMed ID: 10357146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
    Macchi L; Sarfati R; Guicheteau M; Chamlian V; Pourrat O; Gruel Y; Magnin G; Brizard A; Boinot C
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):187-9. PubMed ID: 11030522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
    O'Connor ED; Fraser JF
    Crit Care Resusc; 2006 Dec; 8(4):345-52. PubMed ID: 17227274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
    Elalamy I; Page Y; Viallon A; Tardy B; Conard J; Helft G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):961-74. PubMed ID: 10907445
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
    Davenport A
    Am J Kidney Dis; 1998 Oct; 32(4):E3. PubMed ID: 10074589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
    Schindewolf M; Magnani HN; Lindhoff-Last E
    Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
    Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
    von Lüpke U
    Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
    [No Abstract]   [Full Text] [Related]  

  • 80. [Skin necrosis induced by heparin: apropos of 2 cases].
    Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
    Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.